Corrigendum: Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1548761/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832583605911552000 |
---|---|
author | Alexander J. O’Donovan Seth Gorelik Seth Gorelik Laura M. Nally |
author_facet | Alexander J. O’Donovan Seth Gorelik Seth Gorelik Laura M. Nally |
author_sort | Alexander J. O’Donovan |
collection | DOAJ |
format | Article |
id | doaj-art-89c81279a4e3461fa24c7f307fad6424 |
institution | Kabale University |
issn | 1664-2392 |
language | English |
publishDate | 2025-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Endocrinology |
spelling | doaj-art-89c81279a4e3461fa24c7f307fad64242025-01-28T10:41:18ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-01-011510.3389/fendo.2024.15487611548761Corrigendum: Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapiesAlexander J. O’Donovan0Seth Gorelik1Seth Gorelik2Laura M. Nally3Yale University School of Medicine, Department of Pediatrics, New Haven, CT, United StatesYale University School of Medicine, Department of Pediatrics, New Haven, CT, United StatesBowdoin College, Brunswick, ME, United StatesYale University School of Medicine, Department of Pediatrics, New Haven, CT, United Stateshttps://www.frontiersin.org/articles/10.3389/fendo.2024.1548761/fulltype 1 diabetesstage 1 type 1 diabetesstage 2 type 1 diabetesstage 3 type 1 diabetesteplizumabdisease-modifying therapies |
spellingShingle | Alexander J. O’Donovan Seth Gorelik Seth Gorelik Laura M. Nally Corrigendum: Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies Frontiers in Endocrinology type 1 diabetes stage 1 type 1 diabetes stage 2 type 1 diabetes stage 3 type 1 diabetes teplizumab disease-modifying therapies |
title | Corrigendum: Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies |
title_full | Corrigendum: Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies |
title_fullStr | Corrigendum: Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies |
title_full_unstemmed | Corrigendum: Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies |
title_short | Corrigendum: Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies |
title_sort | corrigendum shifting the paradigm of type 1 diabetes a narrative review of disease modifying therapies |
topic | type 1 diabetes stage 1 type 1 diabetes stage 2 type 1 diabetes stage 3 type 1 diabetes teplizumab disease-modifying therapies |
url | https://www.frontiersin.org/articles/10.3389/fendo.2024.1548761/full |
work_keys_str_mv | AT alexanderjodonovan corrigendumshiftingtheparadigmoftype1diabetesanarrativereviewofdiseasemodifyingtherapies AT sethgorelik corrigendumshiftingtheparadigmoftype1diabetesanarrativereviewofdiseasemodifyingtherapies AT sethgorelik corrigendumshiftingtheparadigmoftype1diabetesanarrativereviewofdiseasemodifyingtherapies AT lauramnally corrigendumshiftingtheparadigmoftype1diabetesanarrativereviewofdiseasemodifyingtherapies |